vs

Side-by-side financial comparison of Sphere 3D Corp. (ANY) and Vivos Therapeutics, Inc. (VVOS). Click either name above to swap in a different company.

Vivos Therapeutics, Inc. is the larger business by last-quarter revenue ($3.8M vs $2.7M, roughly 1.4× Sphere 3D Corp.). On growth, Vivos Therapeutics, Inc. posted the faster year-over-year revenue change (3.4% vs 3.1%). Vivos Therapeutics, Inc. produced more free cash flow last quarter ($-5.3M vs $-23.6M). Over the past eight quarters, Vivos Therapeutics, Inc.'s revenue compounded faster (5.8% CAGR vs -37.4%).

Sphere 3D Corp is a global technology company specializing in cloud computing, data management, and virtualization solutions. It delivers enterprise-grade products and services tailored for small to medium-sized businesses, large enterprise clients, and public sector entities, focusing on optimizing IT infrastructure efficiency and cutting operational costs for end users.

Beam Therapeutics Inc. is an American biotechnology company conducting research in the field of gene therapies and genome editing. The company is headquartered in Cambridge, Massachusetts. In the development of therapies, the company relies on CRISPR base editing and prime editing, whereby single nucleotides in a DNA sequence can be enzymatically modified without producing double-strand breaks.

ANY vs VVOS — Head-to-Head

Bigger by revenue
VVOS
VVOS
1.4× larger
VVOS
$3.8M
$2.7M
ANY
Growing faster (revenue YoY)
VVOS
VVOS
+0.3% gap
VVOS
3.4%
3.1%
ANY
More free cash flow
VVOS
VVOS
$18.3M more FCF
VVOS
$-5.3M
$-23.6M
ANY
Faster 2-yr revenue CAGR
VVOS
VVOS
Annualised
VVOS
5.8%
-37.4%
ANY

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
ANY
ANY
VVOS
VVOS
Revenue
$2.7M
$3.8M
Net Profit
$-6.9M
Gross Margin
78.1%
Operating Margin
-372.7%
-166.8%
Net Margin
-180.3%
Revenue YoY
3.1%
3.4%
Net Profit YoY
-143.8%
EPS (diluted)
$-6.96
$-0.58

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ANY
ANY
VVOS
VVOS
Q4 25
$2.7M
$3.8M
Q3 25
$2.6M
$6.8M
Q2 25
$3.0M
$3.8M
Q1 25
$2.8M
$3.0M
Q4 24
$2.6M
$3.7M
Q3 24
$2.4M
$3.9M
Q2 24
$4.7M
$4.1M
Q1 24
$6.9M
$3.4M
Net Profit
ANY
ANY
VVOS
VVOS
Q4 25
$-6.9M
Q3 25
$-4.2M
$-5.4M
Q2 25
$1.7M
$-5.0M
Q1 25
$-8.8M
$-3.9M
Q4 24
$-2.8M
Q3 24
$104.0K
$-2.6M
Q2 24
$2.1M
$-1.9M
Q1 24
$-4.5M
$-3.8M
Gross Margin
ANY
ANY
VVOS
VVOS
Q4 25
78.1%
Q3 25
25.4%
58.0%
Q2 25
23.8%
55.2%
Q1 25
22.1%
50.0%
Q4 24
56.7%
Q3 24
-16.0%
60.5%
Q2 24
15.2%
65.4%
Q1 24
38.0%
56.7%
Operating Margin
ANY
ANY
VVOS
VVOS
Q4 25
-372.7%
-166.8%
Q3 25
-153.8%
-69.8%
Q2 25
-87.0%
-127.4%
Q1 25
-184.2%
-129.9%
Q4 24
-328.7%
-75.9%
Q3 24
-218.8%
-68.5%
Q2 24
-122.4%
-47.8%
Q1 24
-26.9%
-110.7%
Net Margin
ANY
ANY
VVOS
VVOS
Q4 25
-180.3%
Q3 25
-162.0%
-79.6%
Q2 25
55.2%
-131.2%
Q1 25
-311.9%
-128.1%
Q4 24
-76.4%
Q3 24
4.4%
-67.8%
Q2 24
45.5%
-47.6%
Q1 24
-64.5%
-110.1%
EPS (diluted)
ANY
ANY
VVOS
VVOS
Q4 25
$-6.96
$-0.58
Q3 25
$-0.15
$-0.49
Q2 25
$0.06
$-0.55
Q1 25
$-0.32
$-0.45
Q4 24
$-4.62
$0.41
Q3 24
$0.01
$-0.40
Q2 24
$0.10
$-0.60
Q1 24
$-0.27
$-1.63

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ANY
ANY
VVOS
VVOS
Cash + ST InvestmentsLiquidity on hand
$3.7M
$2.0M
Total DebtLower is stronger
$2.9M
Stockholders' EquityBook value
$23.3M
$-1.5M
Total Assets
$25.1M
$25.2M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ANY
ANY
VVOS
VVOS
Q4 25
$3.7M
$2.0M
Q3 25
$5.3M
$3.1M
Q2 25
$4.7M
$4.4M
Q1 25
$2.8M
$2.3M
Q4 24
$5.4M
$6.3M
Q3 24
$5.0M
$6.3M
Q2 24
$4.3M
$6.9M
Q1 24
$9.3M
$2.6M
Total Debt
ANY
ANY
VVOS
VVOS
Q4 25
$2.9M
Q3 25
Q2 25
Q1 25
Q4 24
$1.2M
Q3 24
$1.2M
Q2 24
$1.2M
Q1 24
Stockholders' Equity
ANY
ANY
VVOS
VVOS
Q4 25
$23.3M
$-1.5M
Q3 25
$29.5M
$2.5M
Q2 25
$32.7M
$4.6M
Q1 25
$30.7M
$4.4M
Q4 24
$39.3M
$8.0M
Q3 24
$35.8M
$7.7M
Q2 24
$33.4M
$6.3M
Q1 24
$27.5M
$582.0K
Total Assets
ANY
ANY
VVOS
VVOS
Q4 25
$25.1M
$25.2M
Q3 25
$31.1M
$25.6M
Q2 25
$34.4M
$26.0M
Q1 25
$34.3M
$11.3M
Q4 24
$43.2M
$15.3M
Q3 24
$44.3M
$15.3M
Q2 24
$44.0M
$15.8M
Q1 24
$42.0M
$11.8M
Debt / Equity
ANY
ANY
VVOS
VVOS
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
0.15×
Q3 24
0.16×
Q2 24
0.19×
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ANY
ANY
VVOS
VVOS
Operating Cash FlowLast quarter
$-16.1M
$-3.8M
Free Cash FlowOCF − Capex
$-23.6M
$-5.3M
FCF MarginFCF / Revenue
-867.3%
-139.7%
Capex IntensityCapex / Revenue
275.4%
40.0%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-40.5M
$-17.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ANY
ANY
VVOS
VVOS
Q4 25
$-16.1M
$-3.8M
Q3 25
$-3.5M
$-4.2M
Q2 25
$-5.8M
$-3.5M
Q1 25
$-4.1M
$-3.8M
Q4 24
$-4.6M
$-2.9M
Q3 24
$290.0K
$-4.2M
Q2 24
$-3.3M
$-3.0M
Q1 24
$-58.0K
$-2.5M
Free Cash Flow
ANY
ANY
VVOS
VVOS
Q4 25
$-23.6M
$-5.3M
Q3 25
$-5.7M
$-4.2M
Q2 25
$-6.0M
$-4.3M
Q1 25
$-5.1M
$-3.9M
Q4 24
$-13.5M
$-3.1M
Q3 24
$-4.3M
$-4.4M
Q2 24
$-3.1M
Q1 24
$-2.7M
FCF Margin
ANY
ANY
VVOS
VVOS
Q4 25
-867.3%
-139.7%
Q3 25
-218.7%
-62.6%
Q2 25
-200.5%
-111.6%
Q1 25
-181.2%
-129.9%
Q4 24
-511.9%
-84.0%
Q3 24
-184.4%
-113.4%
Q2 24
-76.7%
Q1 24
-78.0%
Capex Intensity
ANY
ANY
VVOS
VVOS
Q4 25
275.4%
40.0%
Q3 25
86.5%
1.2%
Q2 25
6.6%
20.2%
Q1 25
36.4%
4.0%
Q4 24
338.7%
4.5%
Q3 24
196.7%
5.0%
Q2 24
0.0%
1.5%
Q1 24
0.0%
4.4%
Cash Conversion
ANY
ANY
VVOS
VVOS
Q4 25
Q3 25
Q2 25
-3.51×
Q1 25
Q4 24
Q3 24
2.79×
Q2 24
-1.55×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ANY
ANY

Segment breakdown not available.

VVOS
VVOS

Services$3.2M84%
Products$594.0K16%

Related Comparisons